PMS-DEXAMETHASONE ELIXIR

Ország: Kanada

Nyelv: angol

Forrás: Health Canada

Aktív összetevők:

DEXAMETHASONE

Beszerezhető a:

PHARMASCIENCE INC

ATC-kód:

H02AB02

INN (nemzetközi neve):

DEXAMETHASONE

Adagolás:

0.5MG

Gyógyszerészeti forma:

ELIXIR

Összetétel:

DEXAMETHASONE 0.5MG

Az alkalmazás módja:

ORAL

db csomag:

100ML

Recept típusa:

Prescription

Terápiás terület:

ADRENALS

Termék összefoglaló:

Active ingredient group (AIG) number: 0106303010; AHFS:

Engedélyezési státusz:

MARKETED

Engedély dátuma:

1992-12-31

Termékjellemzők

_ _
_pms-DEXAMETHASONE ELIXIR _
_Page 1 of 31_
PRESCRIBING INFORMATION
PR
PMS-DEXAMETHASONE ELIXIR
Dexamethasone Elixir, USP
0.5 mg / 5 mL
Corticosteroid
Pharmascience Inc.
6111 Royalmount Avenue, Suite 100
Montréal, QC, Canada
H4P 2T4
Date of Revision:
June 06, 2022
Submission Control Number: 259974
_ _
_ _
_pms-DEXAMETHASONE ELIXIR _
_Page 2 of 31_
TABLE OF CONTENTS
1
INDICATIONS
..............................................................................................................
3
2
CONTRAINDICATIONS
.................................................................................................
4
3
DOSAGE AND
ADMINISTRATION.................................................................................
5
4
OVERDOSAGE
.............................................................................................................
7
5
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING
................................. 7
6
WARNINGS AND PRECAUTIONS
..................................................................................
8
6.1
Special Populations
..........................................................................................
14
6.1.1
Pregnant Women
.......................................................................................
14
6.1.2
Breast-feeding............................................................................................
15
6.1.3
Pediatrics
...................................................................................................
15
6.1.4
Geriatrics
...................................................................................................
15
7
ADVERSE REACTIONS
................................................................................................
16
8
DRUG
INTERACTIONS................................................................................................
18
9
CLINICAL PHARMACOLOGY
.......................................................................................
20
10
STORAGE, STABILITY AND DISPOSAL
.................